AGING AND THE CARDIOVASCULAR SYSTEM: STRUCTURAL AND FUNCTIONAL ADAPTATIONS
Main Article Content
Keywords
Aging, Heart, Cardiovascular system, Structural Adaptation, Functional adaptation
Abstract
Background-With increasing age, there is a higher prevalence of cardiovascular diseases such as hypertension, atherosclerosis, myocardial infarction, and heart failure. Aging induces several significant structural and functional changes in the heart and blood vessels, impacting cardiovascular performance and increasing the risk of cardiovascular diseases (CVD). This article has explored the structural and functional adaptations in the cardiovascular system due to aging and its implications for health and disease. Materials and Methods- This cross sectional observational study was conducted from May 2021 to Jan 2024 in tertiary care hospital, Agra. In this study considering the measurements made from autopsies subjects and data was collected and compared the findings with the standard age and gender. Results: The study included 20 subjects, comprising 11 (55%) male and 9 (45%) female. Among these, 14 (70%) were age more than 60 years. There was significant increase in myocardial thickness with spheroid shape among 16(80%) subjects and more common in male. There was atherosclerosis and vascular stiffness was noted among 14(70%) subjects and more common in female. A significantly higher prevalence of vascular stiffness that indicated increased workload and decrease its reserve capacity and significant differences observed when compared with standard age and gender. Conclusion- Aging induces significant structural and functional changes in the cardiovascular system, increasing the risk of cardiovascular disease. It is hoped that improved understanding of the aged heart will enable the development of therapies which prevent the genesis of HF or at a minimum help clinicians to treat the unique properties of the failing, senescent heart.
References
2. Lloyd-Jones D, Adams RJ, et al. WRITING GROUP MEMBERS. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010; 121(7):e46–e215. [PubMed: 20019324]
3. Gerstenblith G, Frederiksen J, Yin F, Fortuin N. Echocardiographic assessment of a normal adult aging population. Circulation. 1977
4. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res. 1991;
5. Hees PS, Fleg JL, Lakatta EG, Shapiro EP. Left ventricular remodeling with age in normal men versus women: novel insights using three-dimensional magnetic resonance imaging. Am J Cardiol. 2002; 90(11):1231–1236. [PubMed: 12450604]
6. Linzbach AJ, Akuamoa-Boateng E. Changes in the aging human heart. I. Heart weight in the aged. Klin Wochenschr. 1973; 51(4):156–163. [PubMed: 4266200]
7. Scholz DG, Kitzman DW, Hagen PT, Ilstrup DM, Edwards WD. Age-related changes in normal human hearts during the first 10 decades of life. Part I (Growth): A quantitative anatomic study of 200 specimens from subjects from birth to 19 years old. Mayo Clin Proc. 1988; 63(2):126–136. [PubMed: 3276973]
8. Khouri MG, Maurer MS, El-Khoury Rumbarger L. Assessment of age-related changes in left ventricular structure and function by freehand three-dimensional echocardiography. Am J Geriatr Cardiol. 2005; 14(3):118–125. [PubMed: 15886537]
9. Dannenberg AL, Levy D, Garrison RJ. Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). Am J Cardiol. 1989; 64(16):1066–1068. [PubMed: 2530879]
10. Fleg JL, Aronow WS, Frishman WH. Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol. 2011;8:13–28.
11. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933–944
12. North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res 2012; 110:1097–108.
13. Christensen K, Doblhammer G, Rau R, et al. Ageing populations: the challenges ahead. Lancet 2009;374:1196–208.
14. Rapola JM, Virtamo J, Ripatti S, et al. Rand omised trial of a-tocopherol and b-carotene sup plements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349:1715–20.
15. Jarski RW, Hightower KR, Dangovian MI. Vitamin E supplementation, cardiovascular events, and cancer. JAMA 2005;294:425–6; author reply 426.
16. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises, part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107:139–146.
17. Izzo JL Jr, Shykoff BE. Arterial stiffness: clinical relevance, mea surement, and treatment. Rev Cardiovasc Med. 2001;2:29–34.
18. Nakanishi K, Daimon M (2022). Aging and myocardial strain. J Med Ultrason, 49(1):53-60.
19. Evaristi MF, Poirier B, Chénedé X, Lefebvre A, Roccon A, Gillot F, et al (2022). A G-protein-biased S1P1 agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome. PLoS One, 17(1):e0257929.
20. Grassi G, Seravalle G, Bertinieri G, Turri C, Dell'Oro R, Stella ML, et al (2000). Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly. J Hypertens, 18(5):587-93.
21. Yoneyama K, Venkatesh BA, Bluemke DA, McClelland RL, Lima JAC (2017). Cardiovascular magnetic resonance in an adult human population: serial observations from the multi-ethnic study of atherosclerosis. J Cardiovasc Magn Reson, 19(1):52
22. Lieb W, Xanthakis V, Sullivan LM, Aragam J, Pencina MJ, Larson MG, et al (2009). Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring 119(24):3085-92.
23. Cheng S, Xanthakis V, Sullivan LM, Lieb W, Massaro J, Aragam J, et al (2010). Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation, 122(6):570-8
24. Najjar S. Evolving insights into the pathophysiology of heart failure with preserved ejection fraction. Current Cardiovascular Risk Reports. 2009; 3(5):374–379.